Virbac SA (VRBCF)
Virbac Market Cap: 3.655B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| DBV Technologies SA | 534.92M |
| Cellectis SA | 533.73M |
| Innate Pharma SA | 174.22M |
| Inventiva SA | 668.04M |
| Nanobiotix SA | 1.129B |
Market Cap Related Metrics
| PE Ratio | 25.24 |
| PS Ratio | 2.346 |
| PEG Ratio | 1.582 |
| Price to Free Cash Flow | 40.50 |
| Price | 436.32 |
| Earnings Yield | 3.96% |
| PEGY Ratio | 1.545 |
| Operating PE Ratio | 16.93 |
| Normalized PE Ratio | 25.10 |